-

SHAREHOLDER ALERT: Robbins LLP Announces That Neptune Wellness Solutions Inc. (NEPT) is Being Sued for Misleading Shareholders

SAN DIEGO & LAVAL, Quebec--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Neptune Wellness Solutions Inc. (NASDAQ: NEPT) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between July 24, 2019 and February 16, 2021. Neptune operates as an integrated health and wellness company.

If you suffered a loss due to Neptune Wellness Solutions Inc.'s misconduct, click here.

Neptune Wellness Solutions Inc. (NEPT) Misled Investors About the True Costs Associated with the SugarLeaf Acquisition

According to the complaint, on May 9, 2019, Neptune announced it had signed a definitive agreement to acquire assets of SugarLeaf, a registered North Carolina-based commercial hemp company providing extraction services and formulated products. On July 24, 2019, Neptune announced the closing of the SugarLeaf acquisition. During the class period, Neptune touted the benefits of the SugarLeaf acquisition, especially on Neptune's financial results. However, these statements were misleading because defendants failed to disclose that the cost of Neptune's integration of the assets and operations acquired in the SugarLand acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves, and requiring the Company to conduct additional stock offerings to raise more capital.

On February 15, 2021, Neptune issued a press release announcing disappointing financial results for the third quarter of its fiscal year 2021, missing analyst expectations. On this news, Neptune's stock price fell $0.86 per share, or over 30%, to close at $1.94 per share on February 16, 2021. On February 17, 2021, prior to the open of trading, Neptune issued a press release announcing the termination of an at-the-market offering conducted by the Company, selling 9,570,735 of its common shares and raising approximately $18.6 million in gross proceeds. Minutes later, Neptune issued a second press release announcing that the Company was conducting a $55 million registered direct offering. On this news, Neptune's stock fell $0.21 or 10.82% to close at $1.73 per share on February 17, 2021. The stock has yet to recover.

If you purchased shares of Neptune Wellness Solutions Inc. (NEPT) between July 24, 2019 and February 16, 2021, you have until May 17, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Neptune Wellness Solutions Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom